Therefore, we investigated the involvement of ATF3 and RIPK3 in an MCD-induced NASH model, which had fatty liver, elevated blood aminotransferase levels, hepatocellular death, fibrosis-related gene expression and fibrosis (Supplementary Fig. 8a–f). Here, RIPK3 is linked to metabolic dysfunction-associated steatohepatitis.